DoW Epilepsy Idea Development Award
- Response deadline
- Aug 17, 2026 Closed
- Date posted
- May 21, 2026
- Source
- Open notice
Description
Summary: The fiscal year 2026 (FY26) Epilepsy Research Program (ERP) Idea Development Award (IDA) solicits novel research that has the potential to increase understanding of post-traumatic epilepsy (PTE) and associated comorbidities to improve quality of life, especially in Service Members, Veterans and/or their care partners. The work should innovatively challenge existing research paradigms, exhibit high levels of creativity and be a new research direction for the investigator. The IDA is NOT intended to expand or extend previously published findings or continue a line of research already well-established in the Principal Investigator’s (PI’s) laboratory. Distinctive Features: •The IDA offers funding for investigators at all career levels. •**NEW for FY26** An investigator may be named on only one FY26 ERP IDA application as a PI.
Classifications
- NAICS12.420
Documents (1)
- DownloadHT942526ERPIDA_GG.pdfapplication/pdf671 KB
Contacts
- help@ebrap.org301-619-1139
Similar contracts
- DoW Breast Cancer, Clinical Research Extension AwardDue Nov 18, 2026
- DoW Breast Cancer, Breakthrough Award Levels 1 and 2Due Nov 18, 2026
- DoW Reconstructive Transplant, Investigator-Initiated Research AwardDue Nov 4, 2026
- DoW Neurofibromatosis Synergistic Idea AwardDue Sep 22, 2026
- DoW Neurofibromatosis Investigator-Initiated Research AwardDue Sep 22, 2026
- DoW Neurofibromatosis Exploration-Hypothesis Development AwardDue Sep 22, 2026